NCT05816434 is a NA clinical trial of Sleep extension in Sleep, sponsored by Penn State University.

Who is sponsoring NCT05816434?

NCT05816434 is sponsored by Penn State University.

What drugs are being tested in NCT05816434?

Interventions in NCT05816434: Sleep extension.

What condition does NCT05816434 study?

NCT05816434 studies Sleep, Pain.

Is NCT05816434 still recruiting?

NCT05816434 is currently completed. Last updated 2 February 2026.

Last reviewed 2026-02-02 · How we verify

NCT05816434

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

More Sleep: Pain Response to Longer Sleep

Completed NA Last updated 2 February 2026

What this trial tests

NA trial testing Sleep extension in Sleep in 36 participants. Completed in 4 November 2025.

Timeline

18 March 2024

Primary endpoint
4 November 2025

4 November 2025

Quick facts

Lead sponsor	Penn State University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	prevention
Enrollment	36
Start date	18 March 2024
Primary completion	4 November 2025
Estimated completion	4 November 2025
Sites	1 location across United States

Drugs / interventions tested

Sleep extension

Conditions studied

Sleep — all drugs for Sleep →
Pain — all drugs for Pain →

Sponsor

Penn State University

Who can join

Adults 18 to 24, any sex, with Sleep or Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is being done to find out whether extending sleep for at least an hour per night, seven days a week, predicts a higher tolerance and a higher threshold for pain. This is a 21-day study. Participants will be asked to wear sleep- and heart- monitoring watches. Pressure pain and cold pain will be measured at study visits.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Sleep extension

Trials testing the same drug.

NCT06341179 — Effect of Sleep Extension on Body Weight and Learning in Children (More2Sleep) · NA · recruiting
NCT03398902 — Personalizing Sleep Interventions to Prevent Type 2 Diabetes in Community Dwelling Adults With Pre-Diabetes · NA · completed
NCT04057716 — Project REST: Regulation of Eating and Sleep Topography · NA · recruiting
NCT03638102 — Sleep Duration in Women With Previous Gestational Diabetes · NA · completed
NCT03594994 — Metabolic Effects of Sleep Extension in People With Obesity · NA · completed

Other recruiting trials for Sleep

Currently open trials in the same condition.

NCT07413185 — Relationship Between the Severity of Sleep Deprivation in the First 48 Hours Postpartum, Breastfeeding Motivation, and B · recruiting
NCT07401212 — GUTLINK4KIDS Intervention · NA · recruiting
NCT07497698 — Saffron Extract Supplementation and Sleep Quality in Middle-Aged Adults · NA · recruiting
NCT07213908 — Comparing Two School-Based Sleep Health Interventions To Promote Sleep Quality in Youth · NA · recruiting
NCT06670287 — The Use of Multiple Sensors to Track Sleep in Nightshift Workers · NA · recruiting

Other Penn State University trials

Trials by the same sponsor.

NCT07147387 — Lions Hearts: A Community Approach to Multigenerational Cardiovascular Disease Risk · NA · not yet recruiting
NCT07266506 — Development of an Eating Behavior Risk Score · NA · not yet recruiting
NCT07229781 — Mediterranean Diet and Blood Sugar Study · NA · not yet recruiting
NCT07235358 — Cardiometabolic Effects of Pecan Snacking in Prediabetes · NA · not yet recruiting
NCT06823518 — Thrive Initiative Parent-Education Programming Study · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05816434 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Penn State University
Last refreshed: 2 February 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05816434.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing